ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Merus NV

Merus NV (2GH)

42.20
0.80
(1.93%)
Closed 09 December 8:00AM
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
42.20
Bid
41.80
Offer
42.80
Volume
0.00
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
41.40
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

2GH Latest News

Zwischenergebnisse der Monotherapie mit Petosemtamab von Merus zeigen weiterhin klinisch signifikante Aktivität bei 2L+ r/m HNSCC

Zwischenergebnisse der Monotherapie mit Petosemtamab von Merus zeigen weiterhin klinisch signifikante Aktivität bei 2L+ r/m HNSCC Studie mit Petosemtamab in Kombination mit Pembrolizumab bei 1L...

Les données intermédiaires de Merus portant sur le pétosemtamab continuent de démontrer une activité cliniquement significative dans le traitement de 2e ligne et lignes ultérieures du CETC r/m

Les données intermédiaires de Merus portant sur le pétosemtamab continuent de démontrer une activité cliniquement significative dans le traitement de 2e ligne et lignes ultérieures du CETC r/m...

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC Petosemtamab in combination with pembrolizumab in 1L r/m PD-L1 expressing...

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en fonction des données de sécurité et d’efficaci

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en...

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und Wirksamkeitsdaten aus der eNRGy-Studie bekannt

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und...

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TE9Teco 2030 ASA
0.0592 €
(65.36%)
2.11M
A6NAsana Inc
21.00 €
(43.84%)
19.08k
NL8Genesis Ai Corp
0.0214 €
(40.79%)
13.33k
RQ0DWave Quantum Inc
4.814 €
(34.92%)
1.15M
K8DWellfield Technologies Inc
0.0342 €
(34.65%)
30.8k
AXIAtos SE
0.0028 €
(-98.58%)
1.59B
M0YNMynaric AG
1.40 €
(-72.66%)
303.13k
W47Grid Battery Metals Inc
0.0115 €
(-39.47%)
7
47GAGo Metals Corp
0.0202 €
(-36.88%)
3.44k
4APApollo Minerals Ltd
0.0055 €
(-35.29%)
270.7k
AXIAtos SE
0.0028 €
(-98.58%)
1.59B
D7GNel ASA
0.2625 €
(-1.69%)
4.24M
LK1Lake Resources
0.029 €
(-6.75%)
2.32M
TUI1Tui AG
8.40 €
(1.11%)
2.17M
TE9Teco 2030 ASA
0.0592 €
(65.36%)
2.11M

Discussion

View Full Feed
DiscoverGold DiscoverGold 22 seconds ago
$NVDA - Despite this was an up week it looks like the correction that started 2 weeks ago isn't finished. The TSI hasn't generated a bullish crossover yet...
By: CyclesFan | December 8, 2024

• $NVDA - Despite this was an up week it looks like the correction that started 2
NVDA
Pickme2 Pickme2 38 seconds ago
More repeat non sense from the condog 🤡manipulator ...been repeating for years since .31 cents after the last reverse spilt...

Cheap cheap registered friends and family shares coming soon....watch and learn!!
ATMH
IH Admin [Shelly] IH Admin [Shelly] 3 minutes ago
Wow - I don't know anything about dog breeds in general but American Bulldogs seem to be fairly common here or at least mixes. Maybe it's a top breeder in the bulldog world or rare pedigree or something. I was expecting something crazy exotic I'd never heard of before. ha

And, hey,
Macod Macod 3 minutes ago
Yes wishful thinking on their part. Project will be done at federal level, if it gets done
MRGE
xmancometh7 xmancometh7 3 minutes ago
LOL....EITHER PAINKILLERS OR SOME GREAT MARY JANE...IM THINKING..."A THOUSAND FLEAS"!!LMAO
RDAR
waterchaser waterchaser 4 minutes ago
Are you referring to the SCAM OTC?
(where HIRU is listed on the bulletin board… not stock exchange).
over-stated slur and slam of OTC--USA
HIRU
Atown62 Atown62 4 minutes ago
Hi Niko - you forgot to mention the ceo and his dress up time that you and longs absolutely adore so much 

Hhse 
HHSE
Investor082 Investor082 4 minutes ago
Agreed. LP has been screwing shareholders for the last decade.
NWBO
zombywolf zombywolf 5 minutes ago
How about using infringers? This stock goes nowhere until a court validates the patents.
BEGI
infamous infamous 5 minutes ago
who is tweetvestor3?
SFIO
ImjinBridger ImjinBridger 5 minutes ago
No update on Cambodia?
KBLB
Zorax Zorax 6 minutes ago
Works fine for me, never seen a problem.
Clear your cache?
dbergh dbergh 7 minutes ago
, Closed mind, confirmed bigot. Ok.


https://youtu.be/r9URPvejWHk?si=boCiLsAUQEUMxXkZ
Kool Aid Man Kool Aid Man 7 minutes ago
Eddie announced this WAWA gold BS in January..yet despite his yapping about it all year AURI has been rotting at .0001
https://www.otcmarkets.com/otcapi/company/dns/news/document/72369/content

He's made over 600 PR's just on OTC alone not to mention on paid newswire services. H
AURI
mascale mascale 7 minutes ago
I myself even do plant-based meat, reversing in that manner kidney failure. The pitiful deflection from the Jack_Herer over-stated slur and slam of OTC--USA, anyone can now note. Inferences can be noted. The international standing of Qatar--many can now say: Is even on-board with audited financi
HIRU
waterchaser waterchaser 7 minutes ago
He doesn’t know so he won’t respond.
Huzza (or whatever it is that he posts incessantly).
DJT
gp22 gp22 8 minutes ago
$MTEK: Supplies the AI that power $MOB, $PRZO, $LBTH and other companies that need AI. $MTEK the last AI Drone play to get found. Nano-float $MTEK AI also powers tanks, armored vehicles and many cicilian uses. $MTEK just opened a USA Division too.
LBTH MOB MTEK
gp22 gp22 8 minutes ago
$MTEK: Supplies the AI that power $MOB, $PRZO, $LBTH and other companies that need AI. $MTEK the last AI Drone play to get found. Nano-float $MTEK AI also powers tanks, armored vehicles and many cicilian uses. $MTEK just opened a USA Division too.
LBTH MOB MTEK

Your Recent History

Delayed Upgrade Clock